Conservest Capital Advisors’s Globus Medical GMED Stock Holding History

Conservest Capital Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$611K	Sell	7,730 -12	-0.2%	-$1.02K	0.05%	80
2026 Q1	$667K	Sell	7,742 -96	-1%	-$8.62K	0.06%	73
2025 Q4	$684K	Sell	7,838 -186	-2%	-$14.1K	0.06%	74
2025 Q3	$460K	Hold	8,024	–	–	0.04%	81
2025 Q2	$474K	Buy	8,024 +150	+2%	+$9.69K	0.05%	79
2025 Q1	$576K	Sell	7,874 -269	-3%	-$22.2K	0.06%	64
2024 Q4	$674K	Sell	8,143 -558	-6%	-$44K	0.07%	62
2024 Q3	$467K	Hold	8,701	–	–	0.05%	67
2024 Q2	$467K	Hold	8,701	–	–	0.05%	67
2024 Q1	$467K	Hold	8,701	–	–	0.05%	68
2023 Q4	$464K	Sell	8,701 -372	-4%	-$18.1K	0.05%	70
2023 Q3	$450K	Buy	9,073 +102	+1%	+$5.7K	0.05%	64
2023 Q2	$534K	Hold	8,971	–	–	0.06%	62
2023 Q1	$508K	Hold	8,971	–	–	0.06%	62
2022 Q4	$666K	Buy	+8,971	New	+$611K	0.08%	49
2022 Q3	–	Sell	-9,587	Closed	-$577K	–	49
2022 Q2	$538K	Buy	9,587 +211	+2%	+$13.9K	0.07%	52
2022 Q1	$692K	Hold	9,376	–	–	0.08%	50
2021 Q4	$677K	Buy	9,376 +7	+0.1%	+$508	0.07%	55
2021 Q3	$718K	Sell	9,369 -215	-2%	-$17.3K	0.08%	48
2021 Q2	$743K	Sell	9,584 -386	-4%	-$27.4K	0.08%	48
2021 Q1	$615K	Sell	9,970 -201	-2%	-$12.7K	0.07%	47
2020 Q4	$663K	Sell	10,171 -851	-8%	-$48.9K	0.08%	50
2020 Q3	$546K	Sell	11,022 -110	-1%	-$5.67K	0.07%	47
2020 Q2	$531K	Hold	11,132	–	–	0.08%	48
2020 Q1	$473K	Hold	11,132	–	–	0.08%	45
2019 Q4	$655K	Sell	11,132 -1,037	-9%	-$56.3K	0.09%	50
2019 Q3	$622K	Hold	12,169	–	–	0.09%	50
2019 Q2	$515K	Buy	12,169 +500	+4%	+$21.7K	0.08%	54
2019 Q1	$577K	Hold	11,669	–	–	0.09%	52
2018 Q4	$505K	Hold	11,669	–	–	0.08%	53
2018 Q3	$662K	Hold	11,669	–	–	0.1%	47
2018 Q2	$589K	Sell	11,669 -1,000	-8%	-$52.1K	0.09%	51
2018 Q1	$631K	Sell	12,669 -2,750	-18%	-$129K	0.14%	40
2017 Q4	$634K	Sell	15,419 -1,000	-6%	-$35K	0.13%	42
2017 Q3	$488K	Buy	16,419 +1,000	+6%	+$30.5K	0.08%	61
2017 Q2	$511K	Sell	15,419 -500	-3%	-$15.7K	0.11%	45
2017 Q1	$472K	Buy	+15,919	New	+$434K	0.1%	48

Other funds holding GMED

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return

Conservest Capital Advisors's GMED Position: Q2 2026 in Review

Conservest Capital Advisors reduced its Globus Medical (GMED) stake by 0.15% in Q2 2026, selling an estimated $1.02K and leaving 7,730 shares worth $611K. The position accounts for 0.05% of the portfolio, ranked #80.

Conservest Capital Advisors first reported a position in GMED in Q1 2017 and has held it in 37 quarters since. The position peaked at $743K in Q2 2021. 199 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Conservest Capital Advisors held 7,730 shares of Globus Medical worth $611K as of Q2 2026.
Conservest Capital Advisors sold 12 Globus Medical shares in Q2 2026, an estimated $1.02K.
Globus Medical made up 0.05% of Conservest Capital Advisors's portfolio in Q2 2026, its #80 holding.
Conservest Capital Advisors first reported a position in Globus Medical in Q1 2017 and has held it in 37 quarters since.
Conservest Capital Advisors's Globus Medical position peaked at $743K in Q2 2021.
199 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Conservest Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.